Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine

European Journal of Pharmacology

Volumn 346, Issue 1, 1998, Pages 97-102

  Holm, Päivi ^a,b   Kankaanranta, Hannu ^a,b   Metsä Ketelä, Timo ^a   Moilanen, Eeva ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aminotyrosine; Free radical; Mesoionic 3 aryl substituted oxatriazole; Nitric oxide (NO); Nitric oxide (NO) releasing compound; Nitrotyrosine; Peroxynitrite; Superoxide

Indexed keywords

3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; FREE RADICAL; GUANOSINE PHOSPHATE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TETRAZOLIUM; TRIAZOLE DERIVATIVE; TYROSINE;

ARTICLE; CHEMOLUMINESCENCE; CYTOTOXICITY; DRUG ACTIVITY; ELECTRON TRANSPORT; MAMMAL; NEUROTRANSMISSION; PHAGOCYTE; PRIORITY JOURNAL; TARGET CELL;

MOLSIDOMINE; NITRIC OXIDE; OXYGEN; PENICILLAMINE; SUPEROXIDES; TRIAZOLES; TYROSINE;

EID: 0032478585     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00009-0     Document Type: Article

References (32)

1. Auclair, C., Voisin, E., 1985. Nitroblue tetrazolium reduction. In: Greenwald, R.A. (Eds.), CRC handbook of oxygen radical research. CRC Press, Boca Raton, FL, pp. 123-132.
2. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
3. Clark L.C., Wolf R., Granger D., Taylor Z.J. Continuous recording of blood oxygen by polarography. Appl. Physiol. 6:1953;189-193.
4. Corell T., Pedersen S.-B., Lissau B., Moilanen E., Metsä-Ketelä T., Kankaanranta H., Vuorinen P., Vapaatalo H., Rydell E., Andersson R., Marcinkiewicz E., Korbut R., Gryglewski R. Pharmacology of mesoionic oxatriazole derivates in blood, cardiovascular and respiratory systems. Pol. J. Pharmacol. 46:1994;553-566.
5. Crow J.P., Beckman J.S. The role of peroxynitrite in nitric oxide-mediated toxicity. Current Top. Microbiol. Immunology. 196:1995;57-73.
6. Darley-Usmar V.M., Hogg N., O'Leary V.J., Wilson M.T., Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid preoxidation in human low density lipoprotein. Free Radical Res. Commun. 17:1992;9-20.
7. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donor and aspects of preparation and handling of aqueous NO solution. J. Cardiovasc. Pharmacol. 17((Suppl. 3)):1991;25-33.
8. Feelisch M. Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur. Heart J. 14(Suppl. 1):1993;123-132.
9. Feelisch M., Ostrowski J., Noack E. On the mechanism of NO release from sydnominies. J. Cardiovasc. Pharmacol. 14(Suppl. 1):1989;13-22.
10. Graham A., Hogg N., Kalyanaraman B., O'Leary V., Darley-Usmar V., Moncada S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 330:1993;181-185.
11. Gryglewski R.J., Palmer R.M.J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
12. Halliwell B. Oxygen radical, nitric oxide and human inflammatory joint disease. Ann. Rheumatic Dis. 54:1995;505-510.
13. Hogg N., Darley-Usmar V.M., Wilson M.T., Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J. 281:1992;419-424.
14. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radical Res. Commun. 18:1993;195-199.
15. Ignarro L.J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41:1991;485-490.
16. Kankaanranta H., Rydell E., Petersson A.-S., Holm P., Moilanen E., Corell T., Karup G., Vuorinen P., Pedersen S.-B., Wennmalm Å., Metsä-Ketelä T. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivates. Br. J. Pharmacol. 117:1996;401-406.
17. Karup G., Preikschat H., Wilhelmsen E.S., Pedersen S.B., Marcinkiewicz E., Cieslik K., Gryglewski R. Mesoionic oxatriazole derivates - a new group of NO-donors. Pol. J. Pharmacol. 46:1994;541-552.
18. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. FEBS Lett. 350:1994;9-12.
19. Kiechle F.L., Malinski T. Nitric oxide. Biochemistry, pathophysiology, and detection. Am. J. Clin. Pathol. 100:1993;567-575.
20. Kita Y., Hirasawa Y., Maeda K., Nishio M., Yoshida K. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur. J. Pharmacol. 257:1994;123-130.
21. Kosonen O., Kankaanranta H., Vuorinen P., Moilanen E. Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivates. Eur. J. Pharmacol. 337:1997;55-61.
22. Malo-Ranta U., Ylä-Herttuala S., Metsä-Ketelä T., Jaakkola O., Moilanen E., Vuorinen P., Nikkari T. Nitric oxide donor GEA 3162 inhibits endothelial cell mediated oxidation of low density lipoprotein. FEBS Lett. 337:1994;179-183.
23. Menada C., Ermondi G., Fruttero R., Di Stilo A., Ferretti C., Gasco A. Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric release and biological evaluation. J. Med. Chem. 37:1994;4412-4416.
24. Moilanen E., Vuorinen P., Kankaanranta H., Metsä-Ketelä T., Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol. 109:1993;852-858.
25. Moilanen, E., Arola, O., Malo-Ranta, U., Ylä-Herttuala, S., Vuorinen, P., Mets-Ketel, T., Vapaatalo, H., 1994. Nitric oxide donors inhibit neutrophil adhesion to endothelial cells. In: Moncada, S., Feelisch, M., Busse, R., Higgs, E.A. (Eds.), The Biology of Nitric Oxide, Vol. 4, Portland Press, London, pp. 271-275.
26. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: Biochemistry, physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
27. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268:1995;699-722.
28. Radi R., Cosgrove T.P., Beckman J.S., Freeman B.A. Peroxynitrite-induced luminol chemiluminescence. Biochem. J. 290:1993;51-57.
29. Salas E., Moro M.A., Askew S., Hodson H.F., Butler A.R., Radomski M.W., Moncada S. Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br. J. Pharmacol. 112:1994;1071-1076.
30. Van Der Vliet A., Smith D., O'Neill C.A., Kaur H., Darley-Usmar V.M., Cross C.E., Halliwell B. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem. J. 303:1994;295-301.
31. Vilpo, J.A., Vilpo, L.M., Vuorinen, P., Moilanen, E., Metsä-Ketelä, T., 1994. Cytotoxicity of mesoionic oxatriazoles: a novel series of nitric oxide donors. In: Moncada, S., Feelisch, M., Busse, R., Higgs, E.A. (Eds.), The Biology of Nitric Oxide, Vol. 4, Portland Press, London, pp. 286-291.
32. Virta M., Karp M., Vuorinen P. Nitric oxide donor-mediated killing of bioluminescent Escherichia coli. Antimicrob. Agents Chemother. 38:1994;2775-2779.